NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.
NEJM Interviews
00:00
What Are the Main Provisions of the 20 16 Legislation?
The cures two point out has been introduced into congress. The impetus for this is that there is clearly all is more work to be done when it comes to biometical research in the vashack. And so we believe some of the corner stones that we can really invest in through legislation include improvements in data sharing, including also improvements in post market modering.
Play episode from 02:06
Transcript
